Invention Grant
- Patent Title: Substituted quinoxalines as kinase inhibitors
- Patent Title (中): 取代喹喔啉作为激酶抑制剂
-
Application No.: US14639501Application Date: 2015-03-05
-
Publication No.: US09353094B2Publication Date: 2016-05-31
- Inventor: Amarnath Natarajan , Qianyi Chen , Vashti C. Bryant , Rajkumar Rajule
- Applicant: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA , THE BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US NE Lincoln US TX Austin
- Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA,THE BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA,THE BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US NE Lincoln US TX Austin
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: C07D241/44
- IPC: C07D241/44 ; C07D409/14 ; C07D241/42 ; C07D405/04 ; C07D405/14 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D471/04
Abstract:
Disclosed herein are compounds of formula (I) and methods of inhibiting IKKβ and the NF-κB signaling and mTOR pathways.
Public/Granted literature
- US20150274709A1 QUINOXALINE COMPOUNDS AND USES THEREOF Public/Granted day:2015-10-01
Information query
